Physician profile
Guy N Piegari
NPI 1659361095
$7,864.21
in general payments reported to CMS, 2019-2025
25 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,130 · 2020: $740 · 2021: $1,520 · 2022: $1,557 · 2023: $1,119 · 2024: $661 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,895 · Education: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,894.91 |
| Education | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,852.73 | 2019-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Amarin Pharma, INC. | $737.45 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $628.40 | 2019-2022 | |
| Amgen INC. | $618.92 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $379.94 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $377.20 | 2021-2023 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $275.06 | 2019-2025 | Camzyos |
| Microvention, INC. | $200.00 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $195.02 | 2019-2022 | |
| Medtronic, INC. | $171.84 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $171.80 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $149.65 | 2019-2023 | Jardiance |
| Boston Scientific Corporation | $137.69 | 2019-2021 | |
| Medtronic Vascular, INC. | $126.09 | 2019-2020 | |
| Silk Road Medical, INC. | $125.11 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2021 | |
| Cardinal Health 200 LLC | $103.39 | 2019-2020 | |
| Avinger INC. | $87.44 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $86.20 | 2019 | |
| Cordis US Corp. | $83.89 | 2023-2024 | Precise Pro Rx, Brite Tip Radianz |
| Abbott Laboratories | $76.63 | 2019-2023 | Diamondback Peripheral |
| Abiomed | $49.68 | 2020-2023 | Impella |
| Shockwave Medical, INC | $47.41 | 2019 | |
| Chiesi USA, INC. | $41.33 | 2020-2025 | Kengreal |
| Merck Sharp & Dohme LLC | $16.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Piegari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.